Cannabix Begins Commercial Rollout of Marijuana Breath Test
- Cannabix Technologies has begun the commercial rollout of its Marijuana Breath Test, a breath-based system designed to detect recent marijuana use within approximately four hours by identifying delta-9 THC levels above 5 picograms per liter.
- The test addresses a key limitation of traditional marijuana tests (urine, hair, saliva) by focusing on recent consumption, benefiting employers, law enforcement, and safety-sensitive environments requiring immediate use detection.
- The system includes a handheld Breath Collection Unit, disposable Breath Cartridges, and a laboratory testing method managed by strategic partner Omega Laboratories, which integrates testing into its workflow with chain-of-custody and electronic reporting.
- The commercial launch follows extensive preparation including manufacturing, quality control, FCC emissions testing, training, customer support, and marketing, with a peer-reviewed study validating the system’s effectiveness, and the company plans to operate under a recurring-revenue model based on device and cartridge sales.
Cannabix Technologies says it has officially begun the commercial rollout of its Marijuana Breath Test, a new breath-based system designed to detect recent marijuana use rather than past consumption. The Vancouver-based company announced Monday that it has started delivering its Marijuana Breath Test units to select commercial customers in multiple industries, with a broader production scale-up planned as the rollout continues. According to Cannabix, the system is designed to identify delta-9 THC in breath within roughly four hours of use at levels above 5 picograms per liter.
That matters because most traditional marijuana testing methods, including urine, hair and many saliva tests, are generally used to identify prior use rather than whether someone consumed marijuana recently. Cannabix says its breath-based approach is intended to fill that gap for employers, law enforcement and other safety-sensitive settings that want a more immediate indicator of recent use.
The company says the platform includes its handheld Breath Collection Unit, disposable Breath Cartridges and a laboratory-developed testing method operated through Omega Laboratories, its strategic partner in the rollout. Cannabix says Omega has integrated the cartridges into its workflow, including chain-of-custody procedures and electronic reporting.
Cannabix also says the commercial launch follows a series of steps taken over the past several months, including manufacturing preparation, quality-control procedures, FCC emissions testing for the hardware, training material development, customer-support planning and early marketing efforts with Omega and AlcoPro.
The announcement comes shortly after a peer-reviewed paper tied to the system became publicly available in the Journal of Analytical Toxicology. According to the company, the publication supports the system’s ability to detect delta-9 THC as part of breath aerosol analysis.
Cannabix says the Marijuana Breath Test will operate under a recurring-revenue model, with the handheld device required for deployments and disposable cartridges generating revenue with each test.